A rapid clinical response to etifoxine in treatment-resistant obsessive-compulsive disorder: a case report of a patient with comorbid bipolar disorder
Therapeutic Advances in Psychopharmacology · 2026-03 · 16
DOI: 10.1177/20451253261429968 ↗Kurz gefasst
Fallbericht in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 15.03.2026. Verfasst von Pornjira Pariwatcharakul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This case report describes the rapid clinical response to etifoxine, an oral translocator protein 18 kDa (TSPO) ligand, in a patient with severe, treatment-resistant obsessive-compulsive disorder (OCD) with comorbid bipolar I disorder. Despite extensive prior pharmacological treatments and neurosurgical interventions, the patient experienced significant symptom amelioration within days of etifoxine initiation (the Yale-Brown Obsessive-Compulsive Scale (YBOCS) score decreased from 50 to 29). We discussed the potential mechanisms underlying this rapid response, including direct γ-aminobutyric acid (GABA) receptor modulation, increased endogenous neurosteroidogenesis, reduced neuroinflammation, and modulation of the gut-brain axis. This case highlights etifoxine as a novel therapeutic option for treatment-resistant OCD and underscores the need for further research into TSPO ligands in this context.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Clinical Neuropsychiatry MSc Programme, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
ORCID-Profile: Pornjira Pariwatcharakul, Punyisa Prachgosin
Zitieren
APA
Pariwatcharakul, P., & Prachgosin, P. (2026). A rapid clinical response to etifoxine in treatment-resistant obsessive-compulsive disorder: a case report of a patient with comorbid bipolar disorder. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261429968
Vancouver
Pariwatcharakul P, Prachgosin P. A rapid clinical response to etifoxine in treatment-resistant obsessive-compulsive disorder: a case report of a patient with comorbid bipolar disorder. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261429968
BibTeX
@article{Pariwatcharakul2026,
author = {Pariwatcharakul, Pornjira and Prachgosin, Punyisa},
title = {A rapid clinical response to etifoxine in treatment-resistant obsessive-compulsive disorder: a case report of a patient with comorbid bipolar disorder},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261429968}
}
EUVIMED